Oxford Biodynamics Plc Stock Net Income
| OXBOF Stock | USD 0 0.00 0.00% |
As of the 12th of February 2026, Oxford BioDynamics holds the Risk Adjusted Performance of 0.0354, coefficient of variation of 3075.14, and Variance of 491.69. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Oxford BioDynamics, as well as the relationship between them. Please check Oxford BioDynamics Plc coefficient of variation and treynor ratio to decide if Oxford BioDynamics Plc is priced some-what accurately, providing market reflects its current price of 0.002 per share. As Oxford BioDynamics Plc appears to be a penny stock we also advise to check out its information ratio numbers.
Oxford BioDynamics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Oxford BioDynamics' valuation are provided below:Oxford BioDynamics Plc does not presently have any trending fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Oxford |
Oxford BioDynamics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oxford BioDynamics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oxford BioDynamics.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Oxford BioDynamics on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Oxford BioDynamics Plc or generate 0.0% return on investment in Oxford BioDynamics over 90 days. Oxford BioDynamics is related to or competes with Hookipa Pharma, Devonian Health, and ImmunoCellular Therapeutics. Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and bio... More
Oxford BioDynamics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oxford BioDynamics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oxford BioDynamics Plc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0279 | |||
| Maximum Drawdown | 192.86 |
Oxford BioDynamics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oxford BioDynamics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oxford BioDynamics' standard deviation. In reality, there are many statistical measures that can use Oxford BioDynamics historical prices to predict the future Oxford BioDynamics' volatility.| Risk Adjusted Performance | 0.0354 | |||
| Jensen Alpha | 0.6678 | |||
| Total Risk Alpha | (1.90) | |||
| Treynor Ratio | 1.53 |
Oxford BioDynamics February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0354 | |||
| Market Risk Adjusted Performance | 1.54 | |||
| Mean Deviation | 5.82 | |||
| Coefficient Of Variation | 3075.14 | |||
| Standard Deviation | 22.17 | |||
| Variance | 491.69 | |||
| Information Ratio | 0.0279 | |||
| Jensen Alpha | 0.6678 | |||
| Total Risk Alpha | (1.90) | |||
| Treynor Ratio | 1.53 | |||
| Maximum Drawdown | 192.86 | |||
| Skewness | 4.31 | |||
| Kurtosis | 33.57 |
Oxford BioDynamics Plc Backtested Returns
Oxford BioDynamics appears to be out of control, given 3 months investment horizon. Oxford BioDynamics Plc maintains Sharpe Ratio (i.e., Efficiency) of 0.0298, which implies the firm had a 0.0298 % return per unit of risk over the last 3 months. By analyzing Oxford BioDynamics' technical indicators, you can evaluate if the expected return of 0.64% is justified by implied risk. Please evaluate Oxford BioDynamics' Risk Adjusted Performance of 0.0354, coefficient of variation of 3075.14, and Variance of 491.69 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Oxford BioDynamics holds a performance score of 2. The company holds a Beta of 0.46, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Oxford BioDynamics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Oxford BioDynamics is expected to be smaller as well. Please check Oxford BioDynamics' coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and rate of daily change , to make a quick decision on whether Oxford BioDynamics' historical price patterns will revert.
Auto-correlation | 0.48 |
Average predictability
Oxford BioDynamics Plc has average predictability. Overlapping area represents the amount of predictability between Oxford BioDynamics time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oxford BioDynamics Plc price movement. The serial correlation of 0.48 indicates that about 48.0% of current Oxford BioDynamics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.48 | |
| Spearman Rank Test | -0.24 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Oxford BioDynamics Plc reported net income of (6.71 Million). This is 101.97% lower than that of the Healthcare sector and 109.58% lower than that of the Biotechnology industry. The net income for all United States stocks is 101.18% higher than that of the company.
Oxford Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oxford BioDynamics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Oxford BioDynamics could also be used in its relative valuation, which is a method of valuing Oxford BioDynamics by comparing valuation metrics of similar companies.Oxford BioDynamics is currently under evaluation in net income category among its peers.
Oxford Fundamentals
| Return On Equity | -1.45 | |||
| Return On Asset | -0.4 | |||
| Operating Margin | (55.85) % | |||
| Current Valuation | 37.52 M | |||
| Shares Outstanding | 146.71 M | |||
| Shares Owned By Insiders | 30.93 % | |||
| Shares Owned By Institutions | 52.67 % | |||
| Price To Book | 0.19 X | |||
| Price To Sales | 198.91 X | |||
| Revenue | 154 K | |||
| Gross Profit | 116 K | |||
| EBITDA | (6.16 M) | |||
| Net Income | (6.71 M) | |||
| Cash And Equivalents | 4.59 M | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 6.46 M | |||
| Debt To Equity | 0.99 % | |||
| Current Ratio | 2.98 X | |||
| Book Value Per Share | 0.03 X | |||
| Cash Flow From Operations | (5.18 M) | |||
| Earnings Per Share | (0.09) X | |||
| Beta | 1.21 | |||
| Market Capitalization | 37.41 M | |||
| Total Asset | 11.34 M | |||
| Z Score | 3.0 | |||
| Net Asset | 11.34 M |
About Oxford BioDynamics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oxford BioDynamics Plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oxford BioDynamics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oxford BioDynamics Plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Oxford Pink Sheet
Oxford BioDynamics financial ratios help investors to determine whether Oxford Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oxford with respect to the benefits of owning Oxford BioDynamics security.